Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NFLS - Pivotal

NFLS - Pivotal
VC INVESTOR TYPE
Active STATUS
25 PROFESSIONALS
52 INVESTMENTS
36 PORTFOLIO
12 EXITS
Description

Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. Leveraging on Nan Fung Group's capital base and long-term commitment to the area, the company aims to become a partner for scientists, entrepreneurs, corporations and investors in the life science space. Through direct investments via Pivotal bioVenture Partners funds (both in US and China) and fund investments covering full spectrum of the industry (including therapeutics, medical devices and diagnostics) and across different development stages, Nan Fung Life Sciences has presence in both US and Greater China. The firm was founded in 2017 and is based in Hong Kong.

Investor Status
Actively Seeking New Investments
Year Founded
2017
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
PE/Buyout
Primary Office
  • 23rd Floor, Nan Fung Tower
  • 88 Connaught Road C, Central
  • Hong Kong
  • Hong Kong

NFLS - Pivotal Investments (52)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Aligos Therapeutics 10-Jan-2020 Early Stage VC 00000 Biotechnology Pre-Clinical Trials
0000000 10-Dec-2019 00000 00000 0000 Biotechnology Generating Revenue
0000000 09-Oct-2019 00000 00000 000.00 Biotechnology Clinical Trials - Phase 3
00000000 000000000 04-Sep-2019 00000 00000 0000 Biotechnology Stealth
000000 00000000000 27-Aug-2019 00000 00000 00000 Drug Discovery Clinical Trials - Phase 1 0000000 0000000 00
00000 0000000000 18-Jul-2019 00000 000000 Pharmaceuticals Generating Revenue
000000000 10-Jun-2019 00000 00000 0000 Biotechnology Clinical Trials - Phase 2
000000 000000 12-Apr-2019 0000 00000 Diagnostic Equipment Startup
Inozyme Pharma 10-Apr-2019 Early Stage VC 000.00 Biotechnology Startup
Karuna Therapeutics 01-Apr-2019 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2 0000000 0000000 00
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NFLS - Pivotal’s full profile, request a free trial.

NFLS - Pivotal Exits (12)

Company Name Exit Date Exit Type Exit Size Status Buyers
Galera Therapeutics 07-Nov-2019 IPO 0000 Completed
000000 00000000000 28-Jun-2019 000 00000 Completed
0000000 0000000000 15-Feb-2019 000 0000 Completed
00000000 000 08-Feb-2019 000 00000 Completed
00000 0000000000 31-Oct-2018 000 0000 Completed
0000000 0000000000 26-Sep-2018 000 0000 Completed
0000000 21-Jun-2018 000 00000 Completed
000000 00000000000 25-May-2018 000 0000 Completed
WuXi AppTec 08-May-2018 IPO 00000 Completed
Unity Biotechnology 03-May-2018 IPO 0000 Completed
To view this investor’s complete exits history, request access »

NFLS - Pivotal Team (13)

Name Title Deals Funds Boards Office Contact
Info
Vincent Cheung Managing Partner & Founder 0 0 0 San Francisco, CA
Heather Preston MD Managing Partner 00 0 0 San Francisco, CA
Peter Tuxen Bisgaard Managing Partner 00 0 0 San Francisco, CA
Robert Hopfner Ph.D Managing Partner 0 0 0 San Francisco, CA
Ashish Khanna Ph.D Venture Partner 0 0 0 San Francisco, CA

1 Former Team Member

You’re viewing 5 of 13 team members. Get the full list »